3171 results for «3334»
3171 results
Guidelines update
15 Feb 2026 – From PCR Tokyo Valves 2026
This session reviews the latest updates in the ESC/EACTS guidelines for structural heart disease, emphasizing their clinical implications and future trends. Participants will gain understanding of changes in aortic, mitral, and tricuspid valve recommendations, including new age cutoffs, asymptomatic disease management, and the evolving role of...
Future devices and techniques for structural heart disease
15 Feb 2026 – From PCR Tokyo Valves 2026
This session surveys the future landscape of structural heart disease treatment, addressing current limitations in transcatheter valve technologies and presenting emerging devices and techniques for aortic, mitral, and tricuspid valves. Attendees will gain insights into innovations poised to transform therapeutic options for structural heart disease.
PCR Tokyo Valves 2026 Closing Ceremony
15 Feb 2026 – From PCR Tokyo Valves 2026
The Closing Ceremony marks the conclusion of this cardiology conference, providing a formal wrap-up and reflection on the key highlights and advancements presented throughout the event. It serves as an opportunity to acknowledge contributors and set the stage for future initiatives in interventional cardiology.
Mastering techniques from basic to complex - Mitral regurgitation assessment and suitability for TEER
13 Feb 2026 – From PCR Tokyo Valves 2026
Delve into the assessment of mitral regurgitation and the criteria determining suitability for Transcatheter Edge-to-Edge Repair (TEER). This session reviews mitral valve anatomy and the latest clinical data supporting mitral TEER interventions.
Mastering techniques from basic to complex - Tips and tricks for advanced mitral TEER: anatomy and imaging
13 Feb 2026 – From PCR Tokyo Valves 2026
Advance your expertise in mitral TEER by gaining anatomical insights, understanding device interaction with native valve structures, and learning to prevent and manage procedural complications through case-based imaging and live assessments.
RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation
25 Nov 2024 – From PCR London Valves 2024
Join this compelling session focused on the transcatheter treatment of mitral and tricuspid regurgitation. Explore detailed case discussions, including a mitral regurgitation case, a challenging MitraClip procedure, and a severe tricuspid regurgitation case. Discover key takeaways from the RESHAPE, MATTERHORN, and Tri.FR trials, and learn how...
A window into the future - Expanding horizons for patients with long life expectancy with the Evolut FX + TAVI system
25 Nov 2024 – From PCR London Valves 2024
Gain insights into the key considerations when performing TAVI in patients with long life expectancy, including long-term outcomes, valve durability, and the feasibility of future redo-TAVI. Discover the latest data on TAVI in women and patients with small annulus anatomy, as well as a live case...
Tailoring tricuspid interventions with the EVOQUE and PASCAL Precision systems
25 Nov 2024 – From PCR London Valves 2024
Catch up on this engaging session, featuring a parallel case study of two high-risk patients with severe tricuspid regurgitation. Discover how the PASCAL system is used to treat diverse TR anatomies and explore patient selection and management strategies for the EVOQUE system. Watch a recorded case...
The many faces of complex TAVI
25 Nov 2024 – From PCR London Valves 2024
Learn how to navigate challenging cases illustrating the complexities of TAVI procedures and the importance of device selection and implantation technique. Discover strategies for tackling issues like bicuspid aortic stenosis, difficult access, and complex anatomies.
From index procedure to re-valving with a novel self-expanding valve
25 Nov 2024 – From PCR London Valves 2024
Watch this simulation-based symposium to explore the value of the Index Procedure in achieving optimal outcomes during the initial implant, crucial for preventing paravalvular leak, pacemaker dependency, and ensuring precise commissural alignment for coronary access. Discover how the ACURATE neo2/PRIME offers excellent coronary access with its...
TAVR implantation techniques: are they the same for all self-expanding TAV platforms?
25 Nov 2024 – From PCR London Valves 2024
Explore the differences between currently available self-expanding TAVI platforms and how they influence device selection and procedural techniques. A panel of experts discuss the pros and cons of these platforms and valuable tips and tricks to tackle various anatomical challenges effectively.
Mastering structural heart intervention with innovations in imaging
25 Nov 2024 – From PCR London Valves 2024
Explore the future of transcatheter mitral and tricuspid therapies in this innovative session. Learn how advanced imaging techniques like CT/fluoro fusion and 4D intracardiac echocardiography are revolutionizing complex procedures, enhancing both safety and outcomes. Hear from experienced operators as they share their insights on the evolving...
Transforming interventional care for patients with mitral regurgitation: simulation and case-based learning
26 Nov 2024 – From PCR London Valves 2024
Explore the differentiating features of the PASCAL Precision system for the treatment of patients with mitral regurgitation through simulation and case-based learning.
Pushing the boundaries to optimise patient outcomes: from planning to success
26 Nov 2024 – From PCR London Valves 2024
Learn from experts about achieving optimal TAVI outcomes, tailoring approaches for lifetime management, and mastering tips for diverse anatomical challenges.
Align for the future with Myval THV series - From randomised trials to everyday clinical practice
25 Nov 2024 – From PCR London Valves 2024
Through the presentation of several compelling cases, including an 88-year-old male with CKD, RBBB, moderate LV dysfunction, and severe aortic stenosis, a Type 1a bicuspid native AS, and an extraordinary TAVI in an 83-year-old with acute heart failure and comorbidities, this session will dive into the...
Zero-contrast TAVI while using a novel full-body embolic protection filter
26 Nov 2024 – From PCR London Valves 2024
Discover the latest advancements in zero-contrast TAVI through this case-based session. Learn when to consider a zero-contrast protocol, gain practical insights on performing the procedure, and explore a novel full-body embolic protection filter designed to enhance safety during transcatheter interventions.
A dedicated TAVI valve for aortic regurgitation: the J-VALVE solution
26 Nov 2024 – From PCR London Valves 2024
Discover the 30-day outcomes of the novel transfemoral J-VALVE solution, a dedicated TAVI device designed specifically for the treatment of aortic regurgitation. Understand its unique automatic anchoring mechanism and the remarkable left ventricular remodelling it can facilitate.
New frontiers in TAVI: have we reached them?
25 Nov 2024 – From PCR London Valves 2024
Discover the latest advancements in TAVI as we look into the results of the EARLY TAVR and RHEIA trials. Explore how these groundbreaking findings may influence clinical practice guidelines and shape the future of TAVI, as well as the remaining unmet clinical needs in TAVI.
Cinch it if you can - Indirect annuloplasty for functional mitral regurgitation
25 Nov 2024 – From PCR London Valves 2024
This session on mitral regurgitation offers an in-depth look at the EMPOWER trial outcomes, indirect annuloplasty in aFMR, and remodeling with the CARILLON device. Explore the benefits of early treatment for secondary mitral regurgitation, understand the role of left ventricular reverse remodeling, and review the latest...
Align for the future with the novel balloon expandable Myval transcatheter heart valve series
26 Nov 2024 – From PCR London Valves 2024
Watch this session to explore expert insights into best-in-class TAVI practices, from pre-procedural imaging and treatment strategy to procedural tips and post-procedural management. Learn from a compelling case study of an 88-year-old male patient with severe symptomatic aortic stenosis treated with the innovative MyVal Octapro THV....
